Medical Grade Silicone Market Report 2026

Medical Grade Silicone Market Overview

• Medical Grade Silicone market size has reached to $2.55 billion in 2025 • Expected to grow to $3.74 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Growth Of The Medical-Grade Silicone Market Is Supporting Advanced Healthcare Innovations • Market Trend: Advancements In Medical-Grade Silicone Adhesives Is Enhancing Skin Adhesion And Comfort In Wound Care And Wearable Devices • North America was the largest region in 2025.

What Is Covered Under Medical Grade Silicone Market?

Medical grade silicone refers to silicone materials that comply with stringent standards and regulations for use in medical and healthcare applications. These materials are biocompatible, ensuring they are safe for use inside or on the body. They possess properties such as flexibility, durability, and resistance to heat and chemicals, making them suitable for manufacturing medical devices, implants, and other healthcare-related products. The main product types of medical-grade silicone include gels and elastomers, medical-grade silicone fluids, medical-grade silicone resins, and other types. Gels and elastomers are types of medical-grade silicone materials that are flexible and have a soft texture, suitable for applications where conformability and cushioning are needed, such as in wound care dressings and prosthetic devices. The applications are categorized as medical devices, pharmaceuticals, prosthetics and orthopedics, wound care, and others. The end users are hospitals and clinics, pharmaceutical companies, research and academic institutions, and others.

What Is The Medical Grade Silicone Market Growth Forecast?

The medical grade silicone market size is expected to see strong growth in the next few years. It will grow to $3.74 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising demand for advanced implantable devices, increasing focus on patient safety and material compatibility, expanding applications of silicone in pharmaceuticals, growing investments in healthcare manufacturing, rising prevalence of chronic and orthopedic conditions. Major trends in the forecast period include growing use of medical grade silicone in implantable medical devices, rising demand for high-purity and biocompatible silicone materials, increasing adoption of liquid silicone rubber in medical manufacturing, expansion of silicone applications in wound care and prosthetics, growing preference for durable and flexible materials in medical devices.

Global Medical Grade Silicone Market Segmentation

1) By Product Type: Gels And Elastomers, Medical Grade Silicone Fluids, Medical Grade Silicone Resins 2) By Application: Medical Devices, Pharmaceuticals, Prosthetics And Orthopedics, Wound Care 3) By End-User: Hospitals And Clinics, Pharmaceutical Companies, Research and Academic Institutions Subsegments: 1) By Gels and Elastomers: Silicone Gel, Silicone Elastomers 2) By Medical Grade Silicone Fluids: Liquid Silicone Rubber (LSR), Silicone Oil 3) By Medical Grade Silicone Resins: Silicone Resin for Coatings, Silicone Resin for Adhesives

What Is The Driver Of The Medical Grade Silicone Market?

The rise in the production of medical devices and components is expected to propel the growth of the medical-grade silicone market going forward. Medical devices and components refer to instruments, apparatuses, implants, or other products used in healthcare to diagnose, prevent, monitor, treat, or alleviate disease or injury. The demand for medical devices and their components is primarily driven by the need for innovative medical devices that can provide accurate diagnosis and effective treatment options continues to grow. Additionally, the rising focus on preventive healthcare and the shift towards personalized medicine also fuel the demand for tailored devices and diagnostic tools. Medical-grade silicone enhances the performance and safety of medical devices and components, ensuring biocompatibility, durability, and regulatory compliance. For instance, according to the Department of Health and Social Care, a UK-based government agency, registered medical products with the Medicines and Healthcare Products Regulatory Agency (MHRA) increased from approximately 2.25 million in 2022 to around 3.25 million by April 2024. Therefore, a rise in the production of medical devices and components is driving the medical-grade silicone market.

Key Players In The Global Medical Grade Silicone Market

Major companies operating in the medical grade silicone market are Dow Inc., 3M Company, Shin-Etsu Chemical Co. Ltd., Evonik Industries AG, DuPont de Nemours Inc., Wacker Chemie AG, KCC Corporation, Elkem ASA, Momentive Performance Materials, NuSil Technology LLC, Quantum Silicones LLC, Biomerics LLC, ACC Silicones Ltd., Applied Silicone Corporation, Specialty Silicone Products Inc., Primasil Silicones Limited, Silex Silicones Ltd., Wynca Group, Dongguan City Betterly New Materials Co. Ltd., Trelleborg AB, Saint-Gobain Performance Plastics

Global Medical Grade Silicone Market Trends and Insights

Major companies operating in the medical-grade silicone market are developing advanced solutions such as higher-adhesion silicone materials to enhance skin adhesion for advanced wound care and wearable medical devices. Higher-adhesion silicone materials refer to compounds engineered to adhere more effectively to various substrates, offering improved bonding strength and durability in applications such as sealants, adhesives, and coatings. For instance, in October 2023, DuPont de Nemours Inc., a US-based company that manufactures chemicals and science-based products, launched DuPont Live MG 7-9960 soft skin adhesive, which introduces a higher-adhesion, low-cyclic silicone soft skin adhesive (SSA) designed specifically for advanced wound care dressings and medical devices that adhere to skin for extended periods. This product aims to provide gentle adhesion, easy removal, and improved wear performance, addressing the needs of patients with sensitive or fragile skin, including children, the elderly, and those with skin conditions or wounds.

What Are Latest Mergers And Acquisitions In The Medical Grade Silicone Market?

In May 2024, Wacker Chemie AG, a Germany-based chemical products manufacturing company, acquired Bio Med Sciences Inc. for an undisclosed amount. The acquisition will enable Wacker to strengthen its expertise in the research and manufacturing silicone-coated adhesive products and advancements in stick-to-skin applications. BioMed Sciences Inc. is a US-based medical device manufacturing company with silicone-coated medical products.

Regional Outlook

North America was the largest region in the medical grade silicone market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Medical Grade Silicone Market?

The medical-grade silicone market consists of sales of silicone-based orthotics and prosthetics, medical-grade silicone sheets, and medical tubing. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.